Home / Knowledge Centre /
Case study

Managing drug and dose assignments

A classic 3 + 3 study design to find the Maximum Tolerated Dose (MTD) may be straightforward and rule-based, but that does not equate to “simple.” One U.S.-based study team responsible for testing an oncology drug on two continents, quickly realised this. They were dreading the prospect of more than two years of complicated tracking and decision making, most especially because they’d have to be available throughout the night to manage drug and dose assignments in different time zones. Theoretically, their tracking could be done on a spreadsheet, but at what cost? The solution was to let IXRS® handle it all automatically, while the study team slept.

View Resource
Almac Logo

Almac Clinical Technologies

Almac Clinical Technologies is here to help the biopharmaceutical industry bring new therapies to those in need by empowering clinical trial sponsors to proactively manage sites, patients, and clinical trial supplies through our industry-leading Interactive Response Technology (IRT) and expert consultancy.

Almac Clinical Technologies is uniquely positioned to unlock new efficiencies in the clinical supply chain and to help achieve greater predictability in your projects and programs.

Our professionals are dedicated to delivering high-quality Interactive Response Technology (IRT) solutions, dependable professional services, and reliable customer service. Our expertise, energy, and commitment have earned us a reputation as a trusted ally in the drug development process.

Learn More

Download here instantly

This website uses cookies. By continuing to browse the site, you are agreeing to our use of cookies